QurAlis
PrivateLast Round
Series B
Extension
Aug 21, 2025
Total Funding Raised
$161.5M
Company Overview
QurAlis is a biotechnology company that develops precision therapeutics for amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases using genetically validated targets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share
AI Layer
Infrastructure
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
QurAlis Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
QurAlis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B Extension | Aug 21, 2025 | ||||
| Series B | Mar 9, 2023 | ||||
| Series A | May 13, 2020 | ||||
| Seed | Nov 19, 2018 | ||||
| Seed | Apr 5, 2018 |
Key People
Founding team and executive leadership
QurAlis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| The ALS Association | Grant |
| EQT Life Sciences | Series B |
| Dolby Family Ventures | Series A, Series B |
| MP Healthcare Venture Management | Series A, Seed, Series B |
| Mitsui Global Investment | Series A, Series B |
| Acks | Seed |
| Droia Ventures | Series A, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 2, 2025
Presenting Phase 1 data for QRL-101, a selective Kv7.2/7.3 ion channel opener.
- Dec 2, 2025
Presenting Phase 1 trial data at the American Epilepsy Society 2025 Annual Meeting.
QurAlis Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about QurAlis's valuation, stock price, and market status.